PRIVATE AND CONFIDENTIAL November 28, 2018 REGENTYS CORPORATIONPrivate and Confidential • November 30th, 2018 • Generex Biotechnology Corp • Pharmaceutical preparations • Florida
This letter agreement sets forth our agreement and understanding as to the essential terms of the sale to Generex Biotechnology Corporation, Delaware corporation (or an affiliate thereof) (the “Purchaser”) by Regentys Corporation, A Florida corporation (the “Corporation”) of equity securities in the capital of the Corporation equal to fifty-one percent (51%) of the authorized and issued equity securities in the capital of the Corporation on a post-closing basis (the “Transaction”). The parties intend this letter agreement to be binding and enforceable, and that it will inure to the benefit of the parties and their respective successors and assigns.
